CIBC World Markets’s Array Biopharma Inc ARRY Stock Holding History

CIBC World Markets’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$110K	Sell	18,718 -15,170	-45%	-$89.5K	﹤0.01%	1388
2025 Q1	$165K	Buy	33,888 +19,596	+137%	+$95.4K	﹤0.01%	1514
2024 Q4	$86.3K	Buy	+14,292	New	+$86.3K	﹤0.01%	1235
2018 Q2	–	Sell	-145,200	Closed	-$2.37M	–	748
2018 Q1	$2.37M	Buy	+145,200	New	+$2.33M	0.03%	460

CIBC World Markets's ARRY Position: Q2 2025 in Review

CIBC World Markets reduced its Array Biopharma Inc (ARRY) stake by 45% in Q2 2025, selling an estimated $89.5K and leaving 18,718 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #1388.

CIBC World Markets first reported a position in ARRY in Q1 2018 and has held it in 4 quarters since. The position peaked at $2.37M in Q1 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q2 2025.

CIBC World Markets held 18,718 shares of Array Biopharma Inc worth $110K as of Q2 2025.
CIBC World Markets sold 15,170 Array Biopharma Inc shares in Q2 2025, an estimated $89.5K.
Array Biopharma Inc made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #1388 holding.
CIBC World Markets first reported a position in Array Biopharma Inc in Q1 2018 and has held it in 4 quarters since.
CIBC World Markets's Array Biopharma Inc position peaked at $2.37M in Q1 2018.
1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.